Ningbo David Medical Device Co Ltd Cash Flow Reinvestment Rate
Ningbo David Medical Device Co Ltd cash flow reinvestment rate. Ningbo David Medical Device Co Ltd (300314) has a Cash Flow Reinvestment Rate of 0.09x as of September 2025, reinvesting CN¥13.11 Million (capex CN¥13.11 Million ) from operating cash flow of CN¥146.39 Million. Explore debt repayment capacity of Ningbo David Medical Device Co Ltd to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Ningbo David Medical Device Co Ltd (2008–2025)
Cash flow reinvestment rate of Ningbo David Medical Device Co Ltd from 2008 to 2025. Historical reinvestment intensity for Ningbo David Medical Device Co Ltd across 18 annual periods. Explore Ningbo David Medical Device Co Ltd capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Ningbo David Medical Device Co Ltd Cash Flow Reinvestment Rate by Year (2008–2025)
Ningbo David Medical Device Co Ltd cash flow reinvestment rate by year from 2008 to 2025. Year-by-year capital reinvestment analysis for Ningbo David Medical Device Co Ltd. For the full cash flow conversion analysis, see Ningbo David Medical Device Co Ltd (300314) cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.80x | CN¥71.42 Million | CN¥89.25 Million | CN¥55.03 Million | ▼ -50.8% |
| 2024 | 1.63x | CN¥152.66 Million | CN¥93.87 Million | CN¥139.69 Million | ▲ +96.1% |
| 2023 | 0.83x | CN¥112.15 Million | CN¥135.20 Million | CN¥40.39 Million | ▲ +2.1% |
| 2022 | 0.81x | CN¥90.63 Million | CN¥111.57 Million | CN¥49.78 Million | ▼ -58.2% |
| 2021 | 1.94x | CN¥100.03 Million | CN¥51.48 Million | CN¥6.53 Million | ▲ +103.2% |
| 2020 | 0.96x | CN¥131.73 Million | CN¥137.73 Million | CN¥24.20 Million | ▲ +101.7% |
| 2019 | 0.47x | CN¥42.00 Million | CN¥88.57 Million | CN¥9.08 Million | ▼ -67.6% |
| 2018 | 1.46x | CN¥102.24 Million | CN¥69.95 Million | CN¥15.24 Million | ▲ +44.1% |
| 2017 | 1.01x | CN¥55.51 Million | CN¥54.74 Million | CN¥35.51 Million | ▼ -28.6% |
| 2016 | 1.42x | CN¥109.29 Million | CN¥76.95 Million | CN¥59.54 Million | ▼ -79.9% |
| 2015 | 7.05x | CN¥341.42 Million | CN¥48.41 Million | CN¥36.42 Million | ▲ +1175.7% |
| 2014 | 0.55x | CN¥37.47 Million | CN¥67.79 Million | CN¥37.47 Million | ▼ -36.4% |
| 2013 | 0.87x | CN¥49.09 Million | CN¥56.49 Million | CN¥49.09 Million | ▲ +1803.7% |
| 2012 | 0.05x | CN¥4.32 Million | CN¥94.53 Million | CN¥4.32 Million | ▼ -56.2% |
| 2011 | 0.10x | CN¥6.99 Million | CN¥67.02 Million | CN¥6.99 Million | ▼ -81.1% |
| 2010 | 0.55x | CN¥31.38 Million | CN¥56.78 Million | CN¥31.38 Million | ▼ -26.0% |
| 2009 | 0.75x | CN¥30.80 Million | CN¥41.22 Million | CN¥30.80 Million | ▼ -58.2% |
| 2008 | 1.79x | CN¥21.63 Million | CN¥12.10 Million | CN¥21.63 Million | — |